Stock NXG NEXGENRX INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials NexgenRx Inc.

Equities

NXG

CA65337X1042

Investment Management & Fund Operators

Market Closed - Toronto S.E.
Other stock markets
 15:57:41 2024-05-10 EDT 		5-day change 1st Jan Change
0.23 CAD 0.00% Intraday chart for NexgenRx Inc. +4.55% +4.55%
04-05 NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 17.83 13.63 16.78 28.13 18.64 15.52
Enterprise Value (EV) 1 20.3 17.21 17.42 26.22 17.3 14.1
P/E ratio -25 x -65.6 x 8.18 x 7.41 x -833 x -46.7 x
Yield - - - - 3.77% 4.55%
Capitalization / Revenue 2.49 x 1.43 x 1.59 x 2.38 x 1.46 x 1.12 x
EV / Revenue 2.83 x 1.8 x 1.65 x 2.21 x 1.35 x 1.02 x
EV / EBITDA -84.5 x 24 x 7.22 x 7.91 x 11.3 x 12.8 x
EV / FCF -48 x 105 x 30.3 x 14.3 x 31.7 x 10.7 x
FCF Yield -2.08% 0.96% 3.3% 7% 3.15% 9.33%
Price to Book 9.11 x 7.41 x 4.23 x 3.49 x 2.59 x 2.56 x
Nbr of stocks (in thousands) 69,919 69,919 69,919 70,336 70,336 70,531
Reference price 2 0.2550 0.1950 0.2400 0.4000 0.2650 0.2200
Announcement Date 19-04-08 20-04-09 21-03-31 22-03-25 23-04-06 24-04-05
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 7.169 9.54 10.57 11.84 12.78 13.85
EBITDA 1 -0.2404 0.7159 2.412 3.314 1.532 1.104
EBIT 1 -0.5575 0.0935 1.689 2.199 0.2877 -0.1439
Operating Margin -7.78% 0.98% 15.97% 18.57% 2.25% -1.04%
Earnings before Tax (EBT) 1 -0.721 -0.2809 1.81 2.01 0.1345 -0.3051
Net income 1 -0.6969 -0.2079 2.116 4.018 -0.0224 -0.332
Net margin -9.72% -2.18% 20.01% 33.93% -0.18% -2.4%
EPS 2 -0.0102 -0.002973 0.0293 0.0540 -0.000318 -0.004706
Free Cash Flow 1 -0.4227 0.1645 0.5751 1.834 0.5454 1.316
FCF margin -5.9% 1.72% 5.44% 15.49% 4.27% 9.5%
FCF Conversion (EBITDA) - 22.98% 23.84% 55.35% 35.61% 119.18%
FCF Conversion (Net income) - - 27.18% 45.65% - -
Dividend per Share - - - - 0.0100 0.0100
Announcement Date 19-04-08 20-04-09 21-03-31 22-03-25 23-04-06 24-04-05
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 2.47 3.57 0.64 - - -
Net Cash position 1 - - - 1.92 1.33 1.41
Leverage (Debt/EBITDA) -10.29 x 4.991 x 0.2668 x - - -
Free Cash Flow 1 -0.42 0.16 0.58 1.83 0.55 1.32
ROE (net income / shareholders' equity) -35.6% -11% 57.5% 52.7% -0.24% -4.01%
ROA (Net income/ Total Assets) -2.52% 0.3% 4.55% 5.03% 0.65% -0.32%
Assets 1 27.69 -69.78 46.54 79.92 -3.438 103.3
Book Value Per Share 2 0.0300 0.0300 0.0600 0.1100 0.1000 0.0900
Cash Flow per Share 2 0.0100 0.0100 0.0100 0.0300 0.0300 0.0300
Capex 1 0.03 0.05 0.12 0.13 0.39 0.08
Capex / Sales 0.48% 0.53% 1.14% 1.07% 3.04% 0.56%
Announcement Date 19-04-08 20-04-09 21-03-31 22-03-25 23-04-06 24-04-05
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Investment Management & Fund Operators

1st Jan change Capi.
NEXGENRX INC. Stock NexgenRx Inc.
+4.55% 11.94M
BLACKROCK, INC. Stock BlackRock, Inc.
-1.86% 118B
UBS GROUP AG Stock UBS Group AG
+3.26% 95.3B
BROOKFIELD CORPORATION Stock Brookfield Corporation
+13.75% 69.05B
APOLLO GLOBAL MANAGEMENT, INC. Stock Apollo Global Management, Inc.
+20.25% 63.76B
BANK OF NEW YORK MELLON CORPORATION (THE) Stock Bank of New York Mellon Corporation (The)
+12.28% 43.7B
AMERIPRISE FINANCIAL, INC. Stock Ameriprise Financial, Inc.
+14.14% 43.06B
3I GROUP PLC Stock 3i Group plc
+17.76% 34.41B
T. ROWE PRICE GROUP INC. Stock T. Rowe Price Group Inc.
+3.63% 24.92B
STATE STREET CORPORATION Stock State Street Corporation
-1.14% 23.07B
Other Investment Management & Fund Operators
  1. Stock Market
  2. Equities
  3. NXG Stock
  4. Financials NexgenRx Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW